{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:14:48Z","timestamp":1793942088842,"version":"4.8.0"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Nephrotic syndrome is associated with an acquired hypercoagulopathy that is thought to drive its predisposition for venous thromboembolism. Previous studies have suggested that urinary antithrombin (AT) loss leading to acquired AT deficiency is the primary mechanism underlying this hypercoagulopathy, but this hypothesis has not been directly tested. The objectives of this study were to test the influence of AT levels on hypercoagulopathy in nephrotic syndrome patient samples and perform meta-analyses to evaluate the likelihood of AT deficiency in patients with nephrotic syndrome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Samples from three independent nephrotic syndrome cohorts were analyzed. AT antigen and activity assays were performed using ELISA and amidolytic assays, respectively. Plasma thrombin generation, albumin, and urine protein-to-creatinine ratios were determined using established methods. Meta-analyses were performed by combining these new data with previously published data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      AT levels were not consistently related to either plasma albumin or proteinuria. AT was quantitatively related to hypercoagulopathy in adult nephrotic syndrome, whereas AT activity was inconsistently associated with hypercoagulopathy in childhood nephrotic syndrome. Notably, hypercoagulopathy did not differ between patients with normal AT levels and those with levels below the threshold used to define clinical AT deficiency (&lt;70%). Moreover,\n                      <jats:italic toggle=\"yes\">ex vivo<\/jats:italic>\n                      AT supplementation did not significantly alter hypercoagulopathy in AT-deficient plasma samples. The meta-analyses demonstrated that AT deficiency was not a uniform feature of nephrotic syndrome and was more common in children than adults.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These data suggest that AT deficiency plays only a limited role in the mechanisms underlying the acquired hypercoagulopathy of nephrotic syndrome. Moreover, AT deficiency was not present in all patients with nephrotic syndrome and was more likely in children than adults despite the higher risk for venous thromboembolism in adults than children.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.0000000000000047","type":"journal-article","created":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T20:06:05Z","timestamp":1674849965000},"page":"234-244","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":22,"title":["Exploring the Role of Antithrombin in Nephrotic Syndrome\u2013Associated Hypercoagulopathy: A Multi-Cohort Study and Meta-Analysis"],"prefix":"10.2215","volume":"18","author":[{"given":"Eman","family":"Abdelghani","sequence":"first","affiliation":[{"name":"Center for Clinical and Translational Research, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio"},{"name":"Division of Pediatric Hematology\/Oncology\/Blood & Marrow Transplantation, Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda P.","family":"Waller","sequence":"additional","affiliation":[{"name":"Center for Clinical and Translational Research, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelyn J.","family":"Wolfgang","sequence":"additional","affiliation":[{"name":"Center for Clinical and Translational Research, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Stanek","sequence":"additional","affiliation":[{"name":"Biostatistics Resource at Nationwide Children's Hospital, Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir V.","family":"Parikh","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad H.","family":"Rovin","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Smoyer","sequence":"additional","affiliation":[{"name":"Center for Clinical and Translational Research, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio"},{"name":"Division of Nephrology, Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1756-8271","authenticated-orcid":false,"given":"Bryce A.","family":"Kerlin","sequence":"additional","affiliation":[{"name":"Center for Clinical and Translational Research, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio"},{"name":"Division of Pediatric Hematology\/Oncology\/Blood & Marrow Transplantation, Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the PNRC Investigators,","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the NEPTUNE Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"9","key":"B1-20241015","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/jth.12652","article-title":"Kidney disease and risk of venous thromboembolism: a nationwide population-based case-control study","volume":"12","author":"Christiansen","year":"2014","journal-title":"J Thromb Haemost."},{"issue":"9384","key":"B2-20241015","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(03)14184-0","article-title":"Nephrotic syndrome in childhood","volume":"362","author":"Eddy","year":"2003","journal-title":"Lancet."},{"issue":"3","key":"B3-20241015","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2215\/CJN.10131011","article-title":"Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease","volume":"7","author":"Kerlin","year":"2012","journal-title":"Clin J Am Soc Nephrol."},{"issue":"5","key":"B4-20241015","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00467-014-3008-z","article-title":"Healthcare burden of venous thromboembolism in childhood chronic renal diseases","volume":"30","author":"Kerlin","year":"2015","journal-title":"Pediatr Nephrol."},{"issue":"17","key":"B6-20241015","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1056\/NEJM199804233381707","article-title":"The nephrotic syndrome","volume":"338","author":"Orth","year":"1998 10","journal-title":"N Engl J Med."},{"issue":"9","key":"B7-20241015","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1161\/CIRCRESAHA.115.306841","article-title":"Global burden of thrombosis: epidemiologic aspects","volume":"118","author":"Wendelboe","year":"2016","journal-title":"Circ Res."},{"issue":"S1","key":"B8-20241015","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1002\/ajh.23131","article-title":"Current and future management of pediatric venous thromboembolism","volume":"87","author":"Kerlin","year":"2012","journal-title":"Am J Hematol."},{"issue":"8","key":"B9-20241015","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/jth.13741","article-title":"Chronic complications of venous thromboembolism","volume":"15","author":"Winter","year":"2017","journal-title":"J Thromb Haemost."},{"key":"B10-20241015","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.thromres.2021.02.007","article-title":"Nephrotic syndrome disease activity is proportional to its associated hypercoagulopathy","volume":"201","author":"Waller","year":"2021","journal-title":"Thromb Res."},{"issue":"15","key":"B11-20241015","doi-asserted-by":"crossref","first-page":"e14515","DOI":"10.14814\/phy2.14515","article-title":"Nephrotic syndrome-associated hypercoagulopathy is alleviated by both pioglitazone and glucocorticoid which target two different nuclear receptors","volume":"8","author":"Waller","year":"2020","journal-title":"Physiol Rep."},{"issue":"3","key":"B12-20241015","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.thromres.2015.06.031","article-title":"Mechanisms of hypercoagulability in nephrotic syndrome associated with membranous nephropathy as assessed by thromboelastography","volume":"136","author":"Huang","year":"2015","journal-title":"Thromb Res."},{"issue":"2","key":"B13-20241015","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11239-015-1247-x","article-title":"Hypercoagulable state evaluated by thromboelastography in patients with idiopathic membranous nephropathy","volume":"41","author":"Huang","year":"2016","journal-title":"J Thromb Thrombolysis."},{"issue":"5","key":"B14-20241015","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/jth.12891","article-title":"Pituitary adenylate cyclase-activating polypeptide deficiency associated with increased platelet count and aggregability in nephrotic syndrome","volume":"13","author":"Eneman","year":"2015","journal-title":"J Thromb Haemost."},{"issue":"12","key":"B15-20241015","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1681\/ASN.2014111097","article-title":"Disease severity correlates with thrombotic capacity in experimental nephrotic syndrome","volume":"26","author":"Kerlin","year":"2015","journal-title":"J Am Soc Nephrol."},{"issue":"10","key":"B16-20241015","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJMcibr1209459","article-title":"Venous thrombosis in the nephrotic syndrome","volume":"368","author":"Loscalzo","year":"2013","journal-title":"N Engl J Med."},{"issue":"03","key":"B17-20241015","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1055\/s-2007-996100","article-title":"Thromboembolic risks and complications in nephrotic children","volume":"23","author":"Schlegel","year":"1997","journal-title":"Semin Thromb Hemost."},{"issue":"3","key":"B18-20241015","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.thromres.2005.03.030","article-title":"Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management","volume":"118","author":"Singhal","year":"2006","journal-title":"Thromb Res."},{"issue":"6","key":"B19-20241015","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/17474086.2019.1611424","article-title":"Management of antithrombin deficiency: an update for clinicians","volume":"12","author":"Bravo-P\u00e9rez","year":"2019","journal-title":"Expert Rev Hematol."},{"issue":"5","key":"B20-20241015","first-page":"257","article-title":"Acquired antithrombin III deficiency in patients with glomerular proteinuria","volume":"7","author":"Thaler","year":"1978","journal-title":"Haemostasis."},{"issue":"02","key":"B21-20241015","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1055\/s-0038-1647017","article-title":"Plasma and urinary heparin cofactor II levels in patients with nephrotic syndrome","volume":"60","author":"Grau","year":"1988","journal-title":"Thromb Haemost."},{"issue":"4","key":"B22-20241015","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0002-9343(78)90848-3","article-title":"Acquired anti-thrombin III deficiency and thrombosis in the nephrotic syndrome","volume":"65","author":"Kauffman","year":"1978","journal-title":"Am J Med."},{"issue":"1","key":"B23-20241015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000182895","article-title":"Comprehensive study of haemostasis in nephrotic syndrome","volume":"33","author":"Panicucci","year":"1983","journal-title":"Nephron."},{"key":"B24-20241015","first-page":"75","article-title":"Coagulation and thromboembolic complications in the nephrotic syndrome","volume":"13","author":"Cameron","year":"1984","journal-title":"Adv Nephrol Necker Hosp."},{"issue":"3","key":"B25-20241015","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.thromres.2012.04.015","article-title":"Thromboembolic complications in membranous nephropathy patients with nephrotic syndrome-a prospective study","volume":"130","author":"Li","year":"2012","journal-title":"Thromb Res."},{"issue":"6","key":"B26-20241015","first-page":"384","article-title":"Antithrombin III (AT III) and fibrinogen levels in nephrotic syndrome in children","volume":"15","author":"Elidrissy","year":"1985","journal-title":"Haemostasis."},{"issue":"15","key":"B27-20241015","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1200\/JCO.2010.32.8294","article-title":"Prediction of venous thromboembolism in patients with cancer by measuring thrombin generation: results from the Vienna cancer and thrombosis study","volume":"29","author":"Ay","year":"2011","journal-title":"J Clin Oncol."},{"issue":"10","key":"B28-20241015","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1111\/j.1538-7836.2008.03117.x","article-title":"High rate of unprovoked recurrent venous thrombosis is associated with high thrombin-generating potential in a prospective cohort study","volume":"6","author":"Besser","year":"2008","journal-title":"J Thromb Haemost."},{"issue":"12","key":"B29-20241015","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1373\/clinchem.2008.112243","article-title":"Prediction of recurrent venous thromboembolism by endogenous thrombin potential and D-dimer","volume":"54","author":"Eichinger","year":"2008","journal-title":"Clin Chem."},{"issue":"2","key":"B30-20241015","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.athoracsur.2013.04.061","article-title":"Hypercoagulability markers predict thrombosis in single ventricle neonates undergoing cardiac surgery","volume":"96","author":"Emani","year":"2013","journal-title":"Ann Thorac Surg."},{"issue":"2","key":"B31-20241015","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/ajh.23607","article-title":"Hypercoagulability panel testing predicts thrombosis in neonates undergoing cardiac surgery","volume":"89","author":"Emani","year":"2014","journal-title":"Am J Hematol."},{"issue":"1","key":"B32-20241015","first-page":"35","article-title":"Can global assays make anticoagulation safer and more effective?","volume":"14","author":"Hemker","year":"2016","journal-title":"Clin Adv Hematol Oncol."},{"issue":"4","key":"B33-20241015","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/jama.296.4.397","article-title":"Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation","volume":"296","author":"Hron","year":"2006","journal-title":"JAMA."},{"issue":"5","key":"B34-20241015","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/MBC.0b013e32835f93d5","article-title":"Obesity and thrombin-generation profiles in women with venous thromboembolism","volume":"24","author":"Sonnevi","year":"2013","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"3","key":"B35-20241015","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.thromres.2007.04.012","article-title":"The endogenous thrombin potential and the risk of venous thromboembolism","volume":"121","author":"Tripodi","year":"2007","journal-title":"Thromb Res."},{"issue":"9","key":"B36-20241015","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1111\/jth.13043","article-title":"The risk of a first and a recurrent venous thrombosis associated with an elevated D-dimer level and an elevated thrombin potential: results of the THE-VTE study","volume":"13","author":"van Hylckama Vlieg","year":"2015","journal-title":"J Thromb Haemost."},{"issue":"6","key":"B37-20241015","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1365-2141.2007.06738.x","article-title":"Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrence","volume":"138","author":"van Hylckama Vlieg","year":"2007","journal-title":"Br J Haematol."},{"key":"B38-20241015","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.thromres.2018.04.004","article-title":"Evaluation of endogenous thrombin potential among patients with antithrombin deficiency","volume":"166","author":"Kovac","year":"2018","journal-title":"Thromb Res."},{"issue":"25","key":"B39-20241015","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1056\/NEJMoa1201994","article-title":"Thrombosis from a prothrombin mutation conveying antithrombin resistance","volume":"366","author":"Miyawaki","year":"2012","journal-title":"N Engl J Med."},{"key":"B40-20241015","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.thromres.2021.02.029","article-title":"Antithrombin deficiency: a pediatric disorder","volume":"202","author":"Smith","year":"2021","journal-title":"Thromb Res."},{"issue":"2","key":"B41-20241015","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000186735","article-title":"Significance of high levels of heparin cofactor II in the plasma and urine of adult patients with nephrotic syndrome","volume":"60","author":"Toulon","year":"1992","journal-title":"Nephron."},{"issue":"7","key":"B42-20241015","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/clinchem\/43.7.1223","article-title":"Plasma protein abnormalities in nephrotic syndrome: effect on plasma colloid osmotic pressure and viscosity","volume":"43","author":"Joven","year":"1997","journal-title":"Clin Chem."},{"issue":"5","key":"B43-20241015","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/BF02564753","article-title":"Haemostatic parameters in childhood nephrotic syndrome. (Is there any difference in protein C levels between steroid sensitive and resistant groups?)","volume":"27","author":"Yal\u00e7inkaya","year":"1995","journal-title":"Int Urol Nephrol."},{"issue":"2","key":"B44-20241015","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s004670050029","article-title":"Hemostatic problems and thromboembolic complications in nephrotic children","volume":"14","author":"Citak","year":"2000","journal-title":"Pediatr Nephrol."},{"issue":"03","key":"B45-20241015","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1055\/s-0038-1657351","article-title":"Blood viscosity and haemostasis in the nephrotic syndrome","volume":"49","author":"McGinley","year":"1983","journal-title":"Thromb Haemost."},{"issue":"2","key":"B46-20241015","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000188254","article-title":"Hemorheological and hemostatic parameters in children with nephrotic syndrome undergoing steroid therapy","volume":"68","author":"Andr\u00e9","year":"1994","journal-title":"Nephron."},{"issue":"5","key":"B47-20241015","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1600-0609.1979.tb00442.x","article-title":"Antithrombin III and the nephrotic syndrome","volume":"22","author":"J\u00f8rgensen","year":"1979","journal-title":"Scand J Haematol."},{"issue":"6","key":"B48-20241015","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/j.1365-2516.2008.01830.x","article-title":"Inherited antithrombin deficiency: a review","volume":"14","author":"Patnaik","year":"2008","journal-title":"Haemophilia."},{"issue":"4","key":"B49-20241015","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/ki.2012.428","article-title":"Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach","volume":"83","author":"Gadegbeku","year":"2013","journal-title":"Kidney Int."},{"issue":"6","key":"B50-20241015","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1177\/0004563213480137","article-title":"Albumin concentration determined by the modified bromocresol purple method is superior to that by the bromocresol green method for assessing nutritional status in malnourished patients with inflammation","volume":"50","author":"Ueno","year":"2013","journal-title":"Ann Clin Biochem."},{"issue":"3","key":"B52-20241015","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s10157-015-1216-x","article-title":"Evidence-based clinical practice guidelines for nephrotic syndrome 2014","volume":"20","author":"Nishi","year":"2016","journal-title":"Clin Exp Nephrol."},{"key":"B53-20241015","first-page":"142","article-title":"KDIGO clinical practice guideline for glomerulonephritis","volume":"2","year":"2012","journal-title":"Kidney Int Suppl."},{"issue":"4","key":"B54-20241015","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int."},{"issue":"7","key":"B55-20241015","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/nm1438","article-title":"Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo","volume":"12","author":"Bateman","year":"2006","journal-title":"Nat Med."},{"issue":"12","key":"B56-20241015","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1111\/jth.15052","article-title":"Anticoagulant and signaling functions of antithrombin","volume":"18","author":"Rezaie","year":"2020","journal-title":"J Thromb Haemost."},{"issue":"6","key":"B57-20241015","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/archinte.158.6.585","article-title":"Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study","volume":"158","author":"Silverstein","year":"1998","journal-title":"Arch Intern Med."},{"issue":"05","key":"B58-20241015","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1160\/TH16-11-0866","article-title":"High levels of latent antithrombin in plasma from patients with antithrombin deficiency","volume":"117","author":"de la Morena-Barrio","year":"2017","journal-title":"Thromb Haemost."},{"issue":"12","key":"B59-20241015","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1111\/j.1538-7836.2004.01047.x","article-title":"Latent antithrombin and its detection, formation and turnover in the circulation","volume":"2","author":"Mushunje","year":"2004","journal-title":"J Thromb Haemost."},{"issue":"2","key":"B60-20241015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1515\/bchm2.1981.362.1.103","article-title":"Effect of human granulocytic elastase on isolated human antithrombin III","volume":"362","author":"Jochum","year":"1981","journal-title":"Hoppe Seylers Z Physiol Chem."},{"issue":"6","key":"B61-20241015","doi-asserted-by":"crossref","first-page":"8613","DOI":"10.3892\/mmr.2017.7697","article-title":"Low molecular weight heparin may benefit nephrotic remission in steroidsensitive nephrotic syndrome via inhibiting elastase","volume":"16","author":"Zhai","year":"2017","journal-title":"Mol Med Rep."}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000000000000047","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:44:50Z","timestamp":1786369490000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000000000000047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.0000000000000047","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"2022-06-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}